BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18001135)

  • 41. Reduced oxy intermediate observed in D251N cytochrome P450cam.
    Benson DE; Suslick KS; Sligar SG
    Biochemistry; 1997 Apr; 36(17):5104-7. PubMed ID: 9136869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The catalytic pathway of cytochrome p450cam at atomic resolution.
    Schlichting I; Berendzen J; Chu K; Stock AM; Maves SA; Benson DE; Sweet RM; Ringe D; Petsko GA; Sligar SG
    Science; 2000 Mar; 287(5458):1615-22. PubMed ID: 10698731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid kinetics investigations of peracid oxidation of ferric cytochrome P450cam: nature and possible function of compound ES.
    Spolitak T; Dawson JH; Ballou DP
    J Inorg Biochem; 2006 Dec; 100(12):2034-44. PubMed ID: 17095096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electron transfer in the P450cam/PDX complex. The QM/MM e-pathway.
    Wallrapp F; Masone D; Guallar V
    J Phys Chem A; 2008 Dec; 112(50):12989-94. PubMed ID: 18823106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epoxidation of olefins by hydroperoxo-ferric cytochrome P450.
    Jin S; Makris TM; Bryson TA; Sligar SG; Dawson JH
    J Am Chem Soc; 2003 Mar; 125(12):3406-7. PubMed ID: 12643683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient species involved in catalytic dioxygen/peroxide activation by hemoproteins: possible involvement of protonated Compound I species.
    Silaghi-Dumitrescu R; Cooper CE
    Dalton Trans; 2005 Nov; (21):3477-82. PubMed ID: 16234928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the identity and reactivity patterns of the "second oxidant" of the T252A mutant of cytochrome P450cam in the oxidation of 5-methylenenylcamphor.
    Hirao H; Kumar D; Shaik S
    J Inorg Biochem; 2006 Dec; 100(12):2054-68. PubMed ID: 17084458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand interactions in the distal heme pocket of Mycobacterium tuberculosis truncated hemoglobin N: roles of TyrB10 and GlnE11 residues.
    Ouellet Y; Milani M; Couture M; Bolognesi M; Guertin M
    Biochemistry; 2006 Jul; 45(29):8770-81. PubMed ID: 16846220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alcohols on binding of camphor to cytochrome P450cam: spectroscopic and stopped flow transient kinetic studies.
    Murugan R; Mazumdar S
    Arch Biochem Biophys; 2006 Nov; 455(2):154-62. PubMed ID: 17049478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EPR studies on the photoproducts of ferric cytochrome P450cam (CYP101) nitrosyl complexes: effects of camphor and its analogues on ligand-bound structures.
    Masuya F; Tsubaki M; Makino R; Hori H
    J Biochem; 1994 Nov; 116(5):1146-52. PubMed ID: 7896745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hot-spot residues in the cytochrome P450cam-putidaredoxin binding interface.
    Hiruma Y; Gupta A; Kloosterman A; Olijve C; Olmez B; Hass MA; Ubbink M
    Chembiochem; 2014 Jan; 15(1):80-6. PubMed ID: 24302683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex formation of cytochrome P450cam with Putidaredoxin. Evidence for protein-specific interactions involving the proximal thiolate ligand.
    Unno M; Christian JF; Sjodin T; Benson DE; Macdonald ID; Sligar SG; Champion PM
    J Biol Chem; 2002 Jan; 277(4):2547-53. PubMed ID: 11706033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raman evidence for specific substrate-induced structural changes in the heme pocket of human cytochrome P450 aromatase during the three consecutive oxygen activation steps.
    Tosha T; Kagawa N; Ohta T; Yoshioka S; Waterman MR; Kitagawa T
    Biochemistry; 2006 May; 45(17):5631-40. PubMed ID: 16634644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NADH reduction of nitroaromatics as a probe for residual ferric form high-spin in a cytochrome P450.
    Pochapsky TC; Wong N; Zhuang Y; Futcher J; Pandelia ME; Teitz DR; Colthart AM
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):126-133. PubMed ID: 28473297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidation and electronic state dependence of proton transfer in the enzymatic cycle of cytochrome P450eryF.
    Harris DL
    J Inorg Biochem; 2002 Sep; 91(4):568-85. PubMed ID: 12237223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Updating the Paradigm: Redox Partner Binding and Conformational Dynamics in Cytochromes P450.
    Poulos TL; Follmer AH
    Acc Chem Res; 2022 Feb; 55(3):373-380. PubMed ID: 34965086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101).
    Strickler M; Goldstein BM; Maxfield K; Shireman L; Kim G; Matteson DS; Jones JP
    Biochemistry; 2003 Oct; 42(41):11943-50. PubMed ID: 14556625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The second step of the nitric oxide synthase reaction: evidence for ferric-peroxo as the active oxidant.
    Woodward JJ; Chang MM; Martin NI; Marletta MA
    J Am Chem Soc; 2009 Jan; 131(1):297-305. PubMed ID: 19128180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrophobic distal pocket affects NO-heme geminate recombination dynamics in dehaloperoxidase and H64V myoglobin.
    Franzen S; Jasaitis A; Belyea J; Brewer SH; Casey R; MacFarlane AW; Stanley RJ; Vos MH; Martin JL
    J Phys Chem B; 2006 Jul; 110(29):14483-93. PubMed ID: 16854160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.